[{"indications": "Indications\u00a0HIV infection\r\nin combination with other antiretroviral drugs", "name": "EMTRICITABINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Nucleoside reverse transcriptase inhibitors"], "cautions": "Cautions\u00a0\n(From Nucleoside reverse transcriptase inhibitors: British National Formulary)\nNucleoside reverse transcriptase inhibitors; also on discontinuation, monitor patients with hepatitis B (risk of exacerbation\r\nof hepatitis); interactions: Appendix\r\n1 (emtricitabine)", "side-effects": "Side-effects\u00a0see notes above; also abnormal dreams, pruritus,\r\nand hyperpigmentation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/128251.htm", "doses": ["See preparations"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]